10-QPeriod: Q2 FY2010

CVS HEALTH Corp Quarterly Report for Q2 Ended Jun 30, 2010

Filed July 29, 2010For Securities:CVS

Summary

CVS Health Corporation (CVS) reported a slight decrease in net revenues for both the three and six-month periods ending June 30, 2010, compared to the prior year. This was primarily attributed to the termination of large client contracts and a decrease in covered lives under the Medicare Part D program within its Pharmacy Services segment. Despite the revenue dip, gross profit saw a minor decline, indicating some operational resilience. Operating expenses increased slightly, driven by higher litigation and store operating costs, while interest expense also saw a modest rise due to an increased debt balance. The company repurchased a significant amount of its stock during the period, completing its $2.0 billion repurchase program and initiating a new one, signaling a strong focus on returning capital to shareholders. Cash flow from operations improved year-over-year, driven by better working capital management.

Financial Statements
Beta
Revenue$23.89B
Cost of Revenue$18.99B
Gross Profit$5.01B
Operating Expenses$3.52B
Operating Income$1.49B
Interest Expense$136.00M
Net Income$821.00M
EPS (Basic)$0.61
EPS (Diluted)$0.60
Shares Outstanding (Basic)1.36B
Shares Outstanding (Diluted)1.37B

Key Highlights

  • 1Net revenues declined by 3.5% and 1.0% for the three and six-month periods, respectively, primarily due to client contract terminations and reduced Medicare Part D coverage.
  • 2Gross profit saw a modest decrease of 0.6% and 0.3% for the three and six-month periods, respectively.
  • 3Operating expenses increased by 1.9% and 0.5% for the three and six-month periods, attributed to higher litigation and store operating costs.
  • 4The company repurchased approximately $1.5 billion of its common stock during the first six months of 2010, completing its 2009 repurchase program.
  • 5A new $2.0 billion share repurchase program was authorized in June 2010, demonstrating continued commitment to capital return.
  • 6Net cash provided by operating activities increased to $1.7 billion in the first six months of 2010 from $1.3 billion in the prior year period.
  • 7Basic earnings per common share remained stable at $0.61 for the three months and increased to $1.16 for the six months ended June 30, 2010, compared to the prior year.

Frequently Asked Questions

The primary reasons for the decrease in net revenues were the termination of a few large client contracts effective January 1, 2010, and a decrease in the number of covered lives under the company's Medicare Part D program in its Pharmacy Services segment. These impacts were partially offset by same-store sales growth and sales from new retail stores.

CVS Health demonstrated a strong focus on capital return. During the first six months of 2010, the company repurchased approximately $1.5 billion of its common stock, completing its $2.0 billion share repurchase program authorized in November 2009. Additionally, in June 2010, a new $2.0 billion share repurchase program was authorized, indicating continued confidence in the company's financial position and a commitment to shareholder value.

For the Pharmacy Services segment, key metrics include net revenues, gross profit, operating profit, claims processed (mail choice and pharmacy network), and generic dispensing rates. For the Retail Pharmacy segment, key indicators are net revenues, gross profit, operating profit, same-store sales growth (total, pharmacy, and front store), generic dispensing rate, and retail prescriptions filled.

CVS Health is involved in various legal proceedings, including those related to claims processing, antitrust, labor laws, and securities. While the company cannot predict the ultimate outcome of all these matters, management stated that it does not believe the outcome of any of these legal matters will have a material adverse effect on the company's consolidated financial condition. However, they also acknowledge the uncertainty and potential impact of future legal developments.